Indivior Sues Companies for Suboxone Copyright Infringement
05 Avril 2018 - 8:49AM
Dow Jones News
By Carlo Martuscelli
Indivior PLC (INDV.LN) said Thursday that its U.S. subsidiary,
Indivior Inc, has filed new lawsuits against a number of
pharmaceutical companies over patent infringements relating to
generic versions of its opioid disorder treatment, Suboxone.
The U.K.-listed pharmaceutical company said that it has brought
suits against Dr. Reddy's Laboratories Ltd. (RDY), Actavis, Par
Pharmaceutical Cos., Alvogen and Teva Pharmaceutical Industries
Ltd. (TEVA.TV).
The suits maintain that these companies are infringing its U.S.
patent No. 9,931,305, which was issued on April 3. This is not the
first instance of patent litigation it's brought against these
companies, Indivior said.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com
(END) Dow Jones Newswires
April 05, 2018 02:34 ET (06:34 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024